Navigation Links
Large multicenter study suggests new genetic markers for Crohn's disease
Date:3/26/2008

What is believed to be the largest study of its kind for the genetic roots of inflammatory bowel diseases has suggested new links to Crohns Disease as well as further evidence that some people of Jewish descent are more likely to develop it.

The study examined changes in DNA associated with the two most common forms of inflammatory bowel disease (IBD): Crohns Disease (CD), which is most frequently marked by inflammation of the final section of the small bowel (ileum) and parts of the colon, and ulcerative colitis (UC), an inflammation of the internal lining of the rectum and colon.

Results of the study, published in this months edition of Genes and Immunity, included information gleaned from 993 families with IBD, 244 of whom were Ashkenazi Jews. Up to 30 percent of people with IBD in the United States are estimated to have a family history of the condition, and about 25 percent of these families have both CD and UC in the family. People of Ashkenazi Jewish descent are at least twice as likely to develop a form of IBD and are more likely to have familial disease.

This increased risk for some Jewish people makes our study and results especially significant since this is the first sample size of Jewish families, 244, that was large enough to identify novel gene regions for familial predisposition in this ethnic group, says Johns Hopkins gastroenterologist and genetic investigator Steven R. Brant, M.D., senior author of the study.

By analyzing common DNA variations known as single nucleotide polymorphisms, or SNPs, the team found evidence for genes causing familial Crohns Disease in the study population specific to Ashkenazi Jewish families with CD on previously identified areas of chromosomes 1 and 3. They also identified a never-before-identified region of chromosome 13 that was shared by both Jewish and non-Jewish families with CD. Evidence for chromosomal regions that may be linked to UC on chromosome 2 and 19 for Jewish and
'/>"/>

Contact: Eric Vohr
evohr1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related medicine news :

1. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
2. Work time is the largest influence to the duration of a persons sleep
3. Large intensive care study reveals vital recommendations for treatment of brain injury patients
4. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
5. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
6. Preventing or reducing enlarged heart decreases risk of heart failure
7. A Place for Mom, Nations Largest Senior Care Referral Service, Fills a Gap in Employee Benefits
8. AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks with ADHD Medications
9. Worlds Largest Exhibit of Princess Dianas Dresses Hosted by Appleton Museum
10. Largest Privately-Owned Veterinary Practice in the World, Banfield, the Pet Hospital(R), Appoints New Chief Executive Officer
11. Plenary lectures announced for worlds largest osteoporosis congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...swire-FirstCall/ -- The Providence Service,Corpor... A. Norris, the Company,s,Chief Operating Officer...rectors. Mr. Norris, appointment fills the vacanc... Geringer and returns the board to six members. M...Board. , Mr. Norris, age 41, has been with ...
(Date:11/21/2008)... a novel technique to combat cancer, study says,...- Belgian researchers have discovered that some ca...od, and this might lead to new treatments that sta...iferate, all cells in the body need to produce ene...ocess that requires oxygen. Compared with normal c...
(Date:11/21/2008)...Vigorously Protect Investment And Restore Sharehol...re-USNewswire/ -- Dr. Stephen Joffe, Craig Joffe, ...Schedule 13D with the U.S. Securities and Exchange...closing ownership of 11.4% of LCA-Vision, Inc. (Na...site laser vision correction centers in 33 states ...
(Date:11/21/2008)...wswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (N... overwhelmingly approved the proposals submitted t... Pharmaceuticals Industries Ltd. (Nasdaq: TEVA )...helming support of the transaction by the Barr sha...and CEO. "We are pleased with the progress that we...
Breaking Medicine News(10 mins):Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4
...archers at Weill Cornell Medical College could pro...inds. The compound, called SS31, is able to cross...stress molecule recently linked to stroke-related ...eriments, we found that exposing mice to SS31 afte...
...apore have warned people that at least 90 people h...ast five years// in the island republic. They said... clams, and mussels among others. The warning cam...ly man who was bitten by a crab when he was cleani...
...e discovering that some foods and supplements do h...ern// world’s deadliest killer- the ‘big C’. At th...Society, a one-day symposium, more than a dozen re...l be presented. Selected highlights are shown bel...
...ut most of life’s best inventions did sound strang...ics. Cardiologist Michael Barrett of Temple Uni...a study detailing his experiments with ‘recorded h...American College of Cardiology. According to Bar...
Other Medicine News:Health News:Antioxidant Molecule Could Help Minimize Stroke-Linked Brain Damage 2Health News:Emboldened Warriors-Cancer Fighting Foods 2Health News:Emboldened Warriors-Cancer Fighting Foods 3Health News:Heartbeats on IPods - Being ‘cool’ can Help Doctors t 2
(Date:11/19/2008)...ers $5 Million Payment from Roche- , , MONT...ry Pharmaceuticals Corp. (Nasdaq: MEMY ) today a...for its Phase 2 trial of R3487/MEM 3454, its lead ...mpairment associated with schizophrenia (CIAS). T...e 2 trial, triggering a $5.0 million payment from ...
(Date:11/18/2008)... www.christmasseals.org to learn more, make a don...WASHINGTON, Nov. 17 Mil...s month, courtesy of the American Lung Association...nnual fundraising tradition dating back to 1907 wh...erculosis. , , "Most Americans alive toda...
(Date:11/18/2008)...WNE, Va., Nov. 18 Forty...ered at a November national forum to consider cutt...lic health and national economy from outbreaks of ...nced today. , , Among those innovations: ,... American kitchen table that detects highly contag...
(Date:11/18/2008)...ized study will enroll newly diagnosed, elderly AM...Newswire/ -- Celator Pharmaceuticals today announc...ndomized Phase 2 clinical study of CPX-351 (Cytara...with newly diagnosed acute myeloid leukemia (AML).... Feldman, MD at the Weill Medical College of Corn...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3American Lung Association Celebrates 101st Annual Christmas Seals Campaign 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3Life under the laser 4630 1Life under the laser 4630 2Baxa Corporation Named to Inc 5000 for Second Consecutive Year as One of the Fastest Growing Private Companies in the US 7375 1Baxa Corporation Named to Inc 5000 for Second Consecutive Year as One of the Fastest Growing Private Companies in the US 7375 2Journal of Nutrition Health and Aging to be published by Springer 4626 1Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL 28R 29 D Dimer Assay 7367 1Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL 28R 29 D Dimer Assay 7367 2
... Substantial,Reduction of Disease Activity in Pati...rosis , Combination Treatment With Antibiotic Furt... KANSAS CITY, Mo, May 4, 2007 - New data from a ra...tion of Copaxone,(glatiramer acetate injection) al...1 Gadolinium (Gd)-enhancing lesions of the,brain b...
...n Multiple,Sclerosis May Include Direct Activity i... FTY720 stimulates cells,that may help reduce neur...ed by multiple sclerosis , · Separately, an... II clinical study found that the proportion of,pa...lower in the,FTY720 groups compared to placebo , &...
Other Medicine Technology:Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: